Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer
Purpose: Two recent randomized, phase III trials in Asia (ACTS-GC and CLASSIC) documented the survival benefit of postoperative chemotherapy after D2 lymph node dissection in patients with gastric cancer. We sought to determine what factors influenced clinicians' choices of either S-1 or capeci...
Full description
Bibliographic Details
Main Authors: |
Lee, Ha Yeon,
Hwang, In Gyu,
Park, Song-Ee,
Kim, Moon Jin,
Park, Se Hoon,
Kang, Jung Hun,
Kim, Young Saing,
Oh, Sung Yong,
Won, Young-Woong,
Lee, Soon Il,
Ji, Jun Ho,
Chi, Kyong-Choun |
Format: | Online
|
Language: | English |
Published: |
Ivyspring International Publisher
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039392/
|